These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25901047)

  • 21. Racial differences in the outcome of left ventricular dysfunction.
    Dries DL; Exner DV; Gersh BJ; Cooper HA; Carson PE; Domanski MJ
    N Engl J Med; 1999 Feb; 340(8):609-16. PubMed ID: 10029645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart Failure with Preserved Ejection Fraction Trials Have Heterogeneous Control Groups: a Comparison of Kaplan-Meier Curves.
    Luo H; Zhang C; Wang J; Zhu J; Jia X
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):577-580. PubMed ID: 30187346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.
    Rillig A; Magnussen C; Ozga AK; Suling A; Brandes A; Breithardt G; Camm AJ; Crijns HJGM; Eckardt L; Elvan A; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Kuck KH; Ng A; Szumowski L; van Gelder I; Wegscheider K; Kirchhof P
    Circulation; 2021 Sep; 144(11):845-858. PubMed ID: 34328366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
    Carson P; Ziesche S; Johnson G; Cohn JN
    J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study.
    Shan J; Zhang L; Holmes AA; Taub CC
    Am J Med; 2016 Feb; 129(2):222.e1-10. PubMed ID: 26475254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure.
    Piepenburg SM; Faller H; Gelbrich G; Störk S; Warrings B; Ertl G; Angermann CE
    Circ Heart Fail; 2015 May; 8(3):464-72. PubMed ID: 25878325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complex relationship of race to outcomes in heart failure with preserved ejection fraction.
    Gurwitz JH; Magid DJ; Smith DH; Hsu G; Sung SH; Allen LA; McManus DD; Goldberg RJ; Go AS;
    Am J Med; 2015 Jun; 128(6):591-600. PubMed ID: 25554372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.
    Kristensen SL; Preiss D; Jhund PS; Squire I; Cardoso JS; Merkely B; Martinez F; Starling RC; Desai AS; Lefkowitz MP; Rizkala AR; Rouleau JL; Shi VC; Solomon SD; Swedberg K; Zile MR; McMurray JJ; Packer M;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure-A Controlled Trial Investigating Outcomes of Exercise TraiNing) by sex.
    Piña IL; Bittner V; Clare RM; Swank A; Kao A; Safford R; Nigam A; Barnard D; Walsh MN; Ellis SJ; Keteyian SJ;
    JACC Heart Fail; 2014 Apr; 2(2):180-6. PubMed ID: 24720927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
    Jones LG; Sin MK; Hage FG; Kheirbek RE; Morgan CJ; Zile MR; Wu WC; Deedwania P; Fonarow GC; Aronow WS; Prabhu SD; Fletcher RD; Ahmed A; Allman RM
    Circ Heart Fail; 2015 Jan; 8(1):17-24. PubMed ID: 25480782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
    Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
    JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
    Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
    Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure.
    Kadoglou NP; Mandila C; Karavidas A; Farmakis D; Matzaraki V; Varounis C; Arapi S; Perpinia A; Parissis J
    Eur J Prev Cardiol; 2017 May; 24(8):833-839. PubMed ID: 28079427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
    Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD
    J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial differences in incident heart failure during antihypertensive therapy.
    Okin PM; Kjeldsen SE; Dahlöf B; Devereux RB
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):157-64. PubMed ID: 21304095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
    Adedinsewo D; Xu J; Agasthi P; Oderinde A; Adekeye O; Sachdeva R; Rust G; Onwuanyi A
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study.
    O'Brien EC; Greiner MA; Sims M; Hardy NC; Wang W; Shahar E; Hernandez AF; Curtis LH
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):552-9. PubMed ID: 26578621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.